Showing results (311-320 of 762) with videos related to
Sort By:
Pageof 77
Blood|April 25, 2012
Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpuraLuca A Lotta, Haifeng M Wu, Ian J Mackie, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney graftsMarina Noris, Paola Cassis, Nadia Azzollini, et al.Clinical Journal of the American Society of Nephrology : CJASN|July 3, 2010
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotypeMarina Noris, Jessica Caprioli, Elena Bresin, et al.Panminerva Medica|April 28, 2021
Excess mortality in Italy in 2020 by sex and age groups accounting for demographic changes and temporal trends in mortalityGianfranco Alicandro, Carlo La Vecchia, Giuseppe Remuzzi, et al.La Medicina Del Lavoro|December 23, 2021
Excess total mortality in 2021 in Italy was about one third of that observed in 2020Gianfranco Alicandro, Giuseppe Remuzzi, Stefano Centanni, et al.La Medicina Del Lavoro|April 28, 2022
Excess total mortality during the Covid-19 pandemic in Italy: updated estimates indicate persistent excess in recent monthsGianfranco Alicandro, Giuseppe Remuzzi, Stefano Centanni, et al.La Medicina Del Lavoro|June 29, 2022
No excess mortality among working-age Italians during the Omicron wave of Covid-19Gianfranco Alicandro, Giuseppe Remuzzi, Stefano Centanni, et al.Nephron. Clinical Practice|November 12, 2003
Chronic nephropathies: individual risk for progression to end-stage renal failure as predicted by an integrated probabilistic modelBorislav D Dimitrov, Piero Ruggenenti, Rumen Stefanov, et al.Nephrology (Carlton, Vic.)|August 8, 2006
Prevention programmes of progressive renal disease in developing nationsIgor Codreanu, Norberto Perico, Sanjib K Sharma, et al.Journal of the American Society of Nephrology : JASN|November 4, 2006
Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trialPiero Ruggenenti, Annalisa Perna, Maria Ganeva, et al.Pageof 77